Cargando…

A protease activated receptor-2 (PAR-2) activating peptide, tc-LIGRLO-NH(2), induces protease release from mast cells: role in TNF degradation

BACKGROUND: Mast cell (MC)-derived serine proteases have been implicated in a variety of inflammatory processes. We have previously shown that rat peritoneal MC (PMC) express mRNA for protease activated receptor 2 (PAR-2), a G-coupled receptor activated by trypsin-like proteases. Recent evidence als...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alshurafa, Hashem N, Stenton, Grant R, Wallace, John L, Hollenberg, Morley D, Dean Befus, A, Vliagoftis, Harissios
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC503387/ https://www.ncbi.nlm.nih.gov/pubmed/15265236 http://dx.doi.org/10.1186/1471-2210-4-12

Ejemplares similares

Protease-activated receptor-2: Role in asthma pathogenesis and utility as a biomarker of disease severity
por: Gandhi, Vivek Dipak, et al.
Publicado: (2022)

Increased Protease-Activated Receptor-2 (PAR-2) Expression on CD14(++)CD16(+) Peripheral Blood Monocytes of Patients with Severe Asthma
por: Shrestha Palikhe, Nami, et al.
Publicado: (2015)

Growth factors regulate proteinase activated receptor – 2 (PAR-2) on airway epithelium
por: Gandhi, Vivek, et al.
Publicado: (2014)

Targeting of protease activator receptor-2 (PAR-2) antagonist FSLLRY-NH2 as an asthma adjuvant therapy
por: Ocasio-Rivera, Marinel, et al.
Publicado: (2020)

Role of proteinase-activated receptor-2 in allergic sensitization to house dust mite allergens
por: Davidson, Courtney, et al.
Publicado: (2011)

Regulation of Proteinase Activated Receptor-2 on airway epithelium
por: Gandhi, Vivek, et al.
Publicado: (2014)

Proteinase-activated receptor-2 (PAR-2) expression on inflammatory cells in severe asthma
por: Nahirney, Drew, et al.
Publicado: (2014)

Histone 2B Facilitates Plasminogen-Enhanced Endothelial Migration through Protease-Activated Receptor 1 (PAR1) and Protease-Activated Receptor 2 (PAR2)
por: Das, Mitali, et al.
Publicado: (2022)

Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis
por: Lin, Cong, et al.
Publicado: (2015)

Predictive value of protease‐activated receptor‐2 (PAR(2)) in cervical cancer metastasis
por: He, Shengnan, et al.
Publicado: (2020)

Chemical Tools to Image the Activity of PAR-Cleaving Proteases
por: Lee, Irene Y., et al.
Publicado: (2023)

Profiling Gene Expression Induced by Protease-Activated Receptor 2 (PAR2) Activation in Human Kidney Cells
por: Suen, Jacky Y., et al.
Publicado: (2010)

Mast cells and mast cell tryptase enhance migration of human lung fibroblasts through protease-activated receptor 2
por: Bagher, Mariam, et al.
Publicado: (2018)

Attenuated Vasodilator Effectiveness of Protease-Activated Receptor 2 Agonist in Heterozygous par2 Knockout Mice
por: Hennessey, John C., et al.
Publicado: (2013)

Neutrophilia, gelatinase release and microvascular leakage induced by human mast cell tryptase in a mouse model: Lack of a role of protease‐activated receptor 2 (PAR2)
por: Khedr, M. E. M. S., et al.
Publicado: (2018)

Protease-activated receptor 2 (PAR-2) antagonist AZ3451 as a novel therapeutic agent for osteoarthritis
por: Huang, Xiaojian, et al.
Publicado: (2019)

Protease and Protease-Activated Receptor-2 Signaling in the Pathogenesis of Atopic Dermatitis
por: Lee, Sang Eun, et al.
Publicado: (2010)

C781, a β-Arrestin Biased Antagonist at Protease-Activated Receptor-2 (PAR2), Displays in vivo Efficacy Against Protease-Induced Pain in Mice
por: Kume, Moeno, et al.
Publicado: (2023)

Mast cell tryptase stimulates myoblast proliferation; a mechanism relying on protease-activated receptor-2 and cyclooxygenase-2
por: Duchesne, Elise, et al.
Publicado: (2011)

Entamoeba histolytica-secreted cysteine proteases induce IL-8 production in human mast cells via a PAR2-independent mechanism
por: Lee, Young Ah, et al.
Publicado: (2014)

Granzyme K initiates IL-6 and IL-8 release from epithelial cells by activating protease-activated receptor 2
por: Kaiserman, Dion, et al.
Publicado: (2022)

Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2015)

Development and Evaluation of Small Peptidomimetic Ligands to Protease-Activated Receptor-2 (PAR(2)) through the Use of Lipid Tethering
por: Boitano, Scott, et al.
Publicado: (2014)

Acanthamoeba Protease Activity Promotes Allergic Airway Inflammation via Protease-Activated Receptor 2
por: Park, Mi Kyung, et al.
Publicado: (2014)

Activation of Protease-Activated Receptor 2-Mediated Signaling by Mast Cell Tryptase Modulates Cytokine Production in Primary Cultured Astrocytes
por: Zeng, Xiaoning, et al.
Publicado: (2013)

Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases
por: Heuberger, Dorothea M., et al.
Publicado: (2019)

Candida albicans Sap6 Initiates Oral Mucosal Inflammation via the Protease Activated Receptor PAR2
por: Kumar, Rohitashw, et al.
Publicado: (2022)

Work–Life Balance: How Can We Achieve It within the Work Environment?
por: Vliagoftis, Harissios
Publicado: (2016)

Emerging Roles of Protease-Activated Receptors (PARs) in the Modulation of Synaptic Transmission and Plasticity
por: Price, Rachel, et al.
Publicado: (2021)

Induction of Mast Cell Accumulation by Tryptase via a Protease Activated Receptor-2 and ICAM-1 Dependent Mechanism
por: Liu, Xin, et al.
Publicado: (2016)

Protease Profile of Tumor-Associated Mast Cells in Melanoma
por: Atiakshin, Dmitri, et al.
Publicado: (2022)

Correction to: protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases
por: Heuberger, Dorothea M., et al.
Publicado: (2019)

Therapeutic effect of protease-activated receptor 2 agonist SLIGRL-NH(2) on loperamide-induced Sprague-Dawley rat constipation model and the related mechanism
por: Zhang, Yonggang, et al.
Publicado: (2018)

Expression of protease activating receptor-2 (PAR-2) is positively correlated with the recurrence of non-muscle invasive bladder cancer: an immunohistochemical analysis
por: Nakahara, Kozue, et al.
Publicado: (2019)

Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer
por: Liu, Xuan, et al.
Publicado: (2017)

Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy
por: Rwibasira Rudinga, Gamariel, et al.
Publicado: (2018)

Role of protease‐activated receptor‐1 (PAR‐1) in the glomerular filtration barrier integrity
por: Medipally, Ajay, et al.
Publicado: (2022)

Protease Activated Receptor-2 Contributes to Heart Failure
por: Antoniak, Silvio, et al.
Publicado: (2013)

Complement factor C4a does not activate protease‐activated receptor 1 (PAR1) or PAR4 on human platelets
por: Han, Xu, et al.
Publicado: (2020)

Protease-Activated Receptor (PAR)2, but Not PAR1, Is Involved in Collateral Formation and Anti-Inflammatory Monocyte Polarization in a Mouse Hind Limb Ischemia Model
por: van den Hengel, Lisa G., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tdcvh15au7egqv71trdomh93p7